Does daily consumption of two propolis capsules for three months improve the health conditions of obese women?
Phase 2
Recruiting
- Conditions
- ObesityC18.654
- Registration Number
- RBR-5h3sttg
- Lead Sponsor
- niversidade Federal de Alagoas
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Women; between 19 and 40 years of age; obese (Body Mass Index greater than 35 kg/m^2); enrolled in the Bariatric Surgery Program at the Prof. Alberto Antunes University Hospital, Maceió, Alagoas
Exclusion Criteria
Being pregnant or lactating; making use of psychotropic drugs; having undergone recent surgery (last 6 months); being allergic to bee products and; living in a municipality outside the metropolitan region of Maceió (due to the difficulty of moving to the research location)
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected that after 12 weeks of supplementation it will be possible to detect a clinically relevant and statistically significant difference in fasting glycemia between participants in the intervention and placebo groups. Blood samples will be collected, under fasting conditions, by professionals from the technical staff of the Laboratory of Clinical Analysis/Hospital Universitário Prof. Alberto Antunes (Laboratory/HUPAA), where the analyzes will be carried out. Venous blood will be obtained using separator gel tubes and EDTA anticoagulant tubes. Dosing will be performed on Architect c8000 equipment using Abbott kits. The chemiluminescence method will be used. The Laboratory/HUPAA has a certificate of excellence provided by the National Quality Control Program (PNCQ)/Brazilian Society of Clinical Analysis.
- Secondary Outcome Measures
Name Time Method